| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,036,108 ) |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 001 | 9 | NIH | 12/10/2024 | $433,373 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 000 | 3 | NIH | 12/17/2024 | $624,082 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load in US Chinese immigrants | 000 | 3 | NIH | 12/13/2024 | $611,002 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 4 | NIH | 11/21/2024 | $494,601 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 3 | NIH | 1/6/2025 | $683,088 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R13AI188924 | ThymUS 2025 International Conference on Lymphopoiesis | 000 | 1 | NIH | 11/15/2024 | $3,200 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA286669 | Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer | 000 | 2 | NIH | 11/14/2024 | $94,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 001 | 4 | NIH | 11/5/2024 | $420,750 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 11 | NIH | 12/24/2024 | $690,669 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 2 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 2 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 2 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 2 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 2 | NIH | 12/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 000 | 7 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 8 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 000 | 3 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 000 | 2 | NIH | 10/24/2024 | $0 |
| | 2025 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03HS029223 | Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Using Real-World Data | 000 | 2 | AHRQ | 12/13/2024 | $0 |
| | 2025 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R13CA284826 | Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry | 000 | 1 | NIH | 12/18/2024 | $0 |
| | 2025 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA273479 | Pancreatic adenocarcinoma secretome as a dynamic biomarker for patient stromal reprogramming efficacy | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA263415 | Building clinically faithful ex vivo indolent lymphoma models for personalized therapy | 000 | 2 | NIH | 12/4/2024 | $0 |
| | 2025 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA252535 | Neoadjuvant Stroma Modification in Pancreatic Cancer | 000 | 2 | NIH | 12/9/2024 | -$18,657 |
| | 2025 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA222124 | Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention | 000 | 5 | NIH | 12/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $22,161,096 ) (Continued on the next page) |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA282766 | Interrogating MRCK Protein Kinases in Ovarian Cancer | 000 | 1 | NIH | 2/7/2024 | $451,910 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U01CA260369 | Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients | 000 | 4 | NIH | 7/31/2024 | $337,277 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 001 | 2 | NIH | 4/17/2024 | $21,503 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 000 | 2 | NIH | 1/26/2024 | $387,045 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA285674 | Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention | 000 | 1 | NIH | 7/1/2024 | $475,317 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA289703 | Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis | 000 | 1 | NIH | 2/22/2024 | $601,884 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load in US Chinese immigrants | 001 | 2 | NIH | 5/25/2024 | $46,877 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load in US Chinese immigrants | 000 | 2 | NIH | 12/9/2023 | $602,694 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA289161 | NPC1 as a novel therapeutic target in ccRCC | 000 | 1 | NIH | 2/16/2024 | $219,725 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 001 | 10 | NIH | 5/23/2024 | $56,100 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 10 | NIH | 1/23/2024 | $504,900 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA282851 | Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer | 000 | 1 | NIH | 5/23/2024 | $483,395 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | T32CA278766 | Training Grant in Precision Cancer Control | 000 | 2 | NIH | 7/31/2024 | $337,966 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA283396 | Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms | 000 | 2 | NIH | 6/20/2024 | $671,691 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 001 | 2 | NIH | 8/6/2024 | $239,252 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 000 | 2 | NIH | 5/15/2024 | $470,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 000 | 3 | NIH | 4/10/2024 | $249,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 001 | 2 | NIH | 7/25/2024 | $344,654 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 001 | 2 | NIH | 7/25/2024 | $71,111 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 001 | 2 | NIH | 7/25/2024 | $71,111 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 001 | 2 | NIH | 7/25/2024 | $71,111 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 8 | NIH | 11/20/2023 | $433,373 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 000 | 3 | NIH | 2/5/2024 | $387,045 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 000 | 3 | NIH | 2/19/2024 | $64,519 |
|
